|
Octopamine
|
D02.092.471.683.725 |
|
|
Intellectual Disability
|
F03.625.539 |
|
|
Neurodevelopmental Disorders
|
F03.625 |
|
|
Apolipoprotein E2
|
D12.776.521.120.500.249 |
|
|
Apolipoproteins E
|
D12.776.521.120.500 |
|
|
Trihalomethanes
|
D02.455.526.913 |
|
|
Craniosynostoses
|
C05.660.906.364 |
|
|
Melanthiaceae
|
B01.650.940.800.575.912.250.618.875.625 |
|
|
Paracoccus
|
B03.440.400.425.600 |
|
|
Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha
|
D12.776.157.057.080.650 |
|
|
Micrognathism
|
C16.131.850.500.460.457 |
|
|
Mesenchymal Stem Cells
|
A11.872.590.500 |
|
|
Multipotent Stem Cells
|
A11.872.590 |
|
|
Olea
|
B01.650.940.800.575.912.250.583.640.666 |
|
|
Oleaceae
|
B01.650.940.800.575.912.250.583.640 |
|
|
HLA-DRB1 Chains
|
D23.050.301.500.450.400.440.333.500 |
|
|
Response Elements
|
G02.111.570.080.689.675.700 |
|
|
Promoter Regions, Genetic
|
G02.111.570.080.689.675 |
|
|
Sphingolipid Activator Proteins
|
D08.211.790 |
|
|
Odorants
|
N06.230.480 |
|
